MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide): Gold Standard for Colorimetric Cell Viability Assays

Executive Summary. MTT is a cationic, membrane-permeable tetrazolium salt used in cell viability assays, where it is reduced by NADH-dependent oxidoreductases to insoluble purple formazan, directly correlating with cellular metabolic activity (Ha et al. 2021). The reduction process is primarily mitochondrial but also involves extra-mitochondrial enzymes, making the assay robust and broadly applicable. APExBIO supplies MTT (SKU: B7777) at ≥98% purity, with validated solubility and storage parameters (product page). The MTT assay remains a methodological benchmark for in vitro cell proliferation, apoptosis, and metabolic studies across oncology, toxicology, and pharmacology. Limitations exist, such as potential interference from compounds that directly reduce tetrazolium salts, which must be controlled for experimental rigor.

Biological Rationale

Cell viability and proliferation are central parameters in biomedical research, underpinning studies in cancer, toxicology, pharmacology, and regenerative medicine (MTT: The Benchmark Tetrazolium Salt). Quantitative assessment of metabolic activity provides a proxy for viable cell number. MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) serves as a substrate for cellular reductases, enabling a colorimetric readout that is proportional to the number of viable cells. This principle has established MTT as the gold standard for in vitro cell proliferation and metabolic activity assays, bridging fundamental biology and translational research (MTT as a Strategic Linchpin). Unlike trypan blue exclusion or radiolabel-based assays, MTT offers non-radioactive quantification with high sensitivity and throughput compatibility.

Mechanism of Action of MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide)

MTT is a yellow tetrazolium salt that is membrane-permeable and cationic, facilitating entry into intact cells (MTT and the Evolving Science). Once inside, NADH-dependent mitochondrial oxidoreductases, as well as extra-mitochondrial enzymes, reduce MTT to insoluble purple formazan crystals (Ha et al. 2021). The reaction is summarized as:

• MTT (tetrazolium) + NADH (or NADPH) → formazan (insoluble) + NAD⁺

Formazan accumulates within the cell, and the intensity of purple coloration correlates linearly with viable cell number under optimized conditions. After incubation (typically 1–4 hours at 37°C), the formazan is solubilized (commonly using DMSO), and absorbance is measured at 540–570 nm. This workflow allows quantitative measurement of metabolic activity in a high-throughput format.

Evidence & Benchmarks

• MTT reduction directly correlates with viable, metabolically active cell number in cultured cells (Ha et al. 2021).
• MTT is soluble at ≥41.4 mg/mL in DMSO, ≥18.63 mg/mL in ethanol, and ≥2.5 mg/mL in water with ultrasonic assistance (APExBIO product page).
• Optimal storage for MTT is at -20°C, with solutions intended for short-term use only (APExBIO product page).
• MTT-based assays have been validated as highly sensitive and reproducible for screening anticancer agents and apoptosis inducers (internal review).
• MTT outperforms second-generation, negatively charged tetrazolium salts in terms of cell permeability and assay sensitivity (internal benchmark).

Applications, Limits & Misconceptions

MTT is broadly applied in cancer research, apoptosis assays, drug screening, and metabolic activity measurements. It has been pivotal in studies of multidrug resistance and genome editing (MTT in Multidrug Resistance). However, certain experimental caveats require attention.

Common Pitfalls or Misconceptions

• MTT reduction does not distinguish between cell proliferation and increased metabolic activity per cell—interpretation must consider underlying biology.
• Compounds with redox activity (e.g., ascorbate, certain phenolics) can directly reduce MTT, resulting in false-positive signals.
• Formazan may accumulate outside the cell in some protocols, potentially leading to underestimation if not fully solubilized.
• MTT is not suitable for live-cell kinetic imaging due to formazan insolubility and cytotoxicity upon prolonged exposure.
• Assay performance can vary by cell type, density, and metabolic state; standard curve calibration is essential.

For an expanded discussion of these caveats and troubleshooting strategies, see MTT: The Benchmark Tetrazolium Salt, which this article extends with new solubility benchmarks and stability data from the APExBIO B7777 kit.

Workflow Integration & Parameters

MTT is supplied by APExBIO at ≥98% purity (SKU: B7777). Recommended stock concentrations are 5–10 mg/mL in DMSO or PBS. Working solution preparation requires complete dissolution, achievable at ≥41.4 mg/mL in DMSO or ≥2.5 mg/mL in water (ultrasonic assistance recommended). Standard assay conditions are as follows:

• Cell seeding: 5,000–20,000 cells/well (96-well plate)
• MTT addition: 0.5 mg/mL final concentration
• Incubation: 1–4 hours at 37°C, 5% CO₂
• Formazan solubilization: DMSO or isopropanol, 10–20 min at room temperature
• Absorbance measurement: 540–570 nm, plate reader

For optimal stability, store MTT powder at -20°C, desiccated. Freshly prepare solutions before use and avoid repeated freeze-thaw cycles (APExBIO product page).

For a step-by-step protocol and troubleshooting guidance, see MTT: The Gold Standard Tetrazolium Salt. This article clarifies the mechanistic underpinnings and provides updated reagent compatibility data.

Conclusion & Outlook

MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) remains the gold standard for colorimetric cell viability and metabolic assays. Its robust correlation with viable cell number, high sensitivity, and compatibility with high-throughput workflows underpin its enduring utility. APExBIO’s B7777 kit delivers validated purity, solubility, and stability data supporting reproducibility. Ongoing research is extending MTT applications into multidrug resistance, genome editing, and advanced translational models (MTT in Multidrug Resistance). For further mechanistic insights and evolving applications, see MTT and the Evolving Science, which this dossier updates with comprehensive workflow integration and recent evidence from peer-reviewed sources.